Almac and Exco InTouch Form Alliance to Deliver Patient Compliance and ePRO Services Using Multiple Technologies

Article

Company News Release

The Almac Group and Exco InTouch announced that Almac’s Clinical Technologies business unit has formed an exclusive integrated patient management alliance with Exco InTouch, a firm specializing in patient recruitment, retention, compliance, and ePRO services. The alliance will be focused on the integration of both technology and processes by both firms to deliver patient management, compliance, retention, and ePRO service offerings to sponsors of clinical trials.

The Almac-Exco InTouch offering helps to engage, retain, and enhance compliance of patients from the earliest stages of recruitment and throughout the course of a trial. Exco InTouch will work with Almac to integrate its retention and compliance technology solutions with Almac’s IXRS® technology, an integrated phone and web platform. This industry offering will allow patients to receive messages for key elements of their required study conduct using Short Message Service (SMS) text messages,  emails, or phone calls. Examples of messages include reminders to attend clinic visits or to fill out patient diaries, medication prompts, notices to attend appointments in a fasted state, to return unused medication, and even encouragement messages to keep all patients motivated to participate in the clinical trial.

 The Almac-Exco InTouch alliance offers sponsors the benefit of alleviating clinical trial site personnel of significant administrative burdens and activities relating to protocol compliance. Moreover, it provides biopharmaceutical firms a way to ease a patient’s journey through the clinical trial process using familiar technologies that are both popular and ubiquitous, including phone, web, text messages and email. The solution keeps patients on track during a trial and offers them an “electronic tap on the shoulder” in their native languages to help drive compliance.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.